Literature DB >> 3941165

Contribution of plasma androstenedione to 5 alpha-androstanediol glucuronide in women with idiopathic hirsutism.

A Gompel, F Wright, F Kuttenn, P Mauvais-Jarvis.   

Abstract

To confirm that plasma delta 4 androstenedione (delta 4) is the main precursor for 5 alpha-androstane-3 alpha, 17 beta-diol glucuronide (Adiol G) in patients with idiopathic hirsutism (IH), delta 4 was cutaneously applied to five normal women and five women with IH. Several parameters of androgen metabolism were assayed basally and throughout the studies. Those included plasma delta 4, testosterone, and dihydrotestosterone as well as urinary Adiol G and testosterone glucuronide excretion. Under basal conditions plasma testosterone, delta 4, and dihydrotestosterone did not differ significantly between the two groups of subjects. Urinary Adiol G excretion was significantly higher (P less than 0.01) in IH patients [123 +/- 36 (SE) micrograms/24 h] than in the normal women group (45 +/- 20 micrograms/24 h). After percutaneous administration of delta 4, plasma delta 4 increased in both groups by nearly 600% and there was a 300% increase in Adiol G excretion in IH patients (336 +/- 57 micrograms/24 h), whereas only a 50% increase occurred in normal women (65 +/- 17 micrograms/24 h). We postulate that plasma delta 4 may be the main precursor accounting for the increased production of urinary Adiol G in women with IH, in whom hirsutism may be due to a high 5 alpha-reductase activity. Indeed, 5 alpha-reductase as measured in vitro in pubic skin was significantly higher in hirsute patients (224 +/- 66 fmol/mg skin X h) than in normal women (45 +/- 15 fmol/mg skin X h).

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3941165     DOI: 10.1210/jcem-62-2-441

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  5 in total

Review 1.  Hirsutism: pilosebaceous unit dysregulation. Role of peripheral and glandular factors.

Authors:  V Toscano
Journal:  J Endocrinol Invest       Date:  1991-02       Impact factor: 4.256

2.  Plasma 3 alpha-androstanediol glucuronide in precocious adrenarche.

Authors:  R Balducci; G Finocchi; A Mangiantini; P Bianchi; R Guglielmi; V Toscano
Journal:  J Endocrinol Invest       Date:  1993-02       Impact factor: 4.256

3.  A role for a non-androgenic anovulant in the management of hirsutism.

Authors:  T J McKenna; S K Cunningham
Journal:  Ir J Med Sci       Date:  1991-07       Impact factor: 1.568

Review 4.  Alopecia and hirsuties. Current concepts in pathogenesis and management.

Authors:  J H Barth
Journal:  Drugs       Date:  1988-01       Impact factor: 9.546

5.  Evidence for Increased 5α-Reductase Activity During Early Childhood in Daughters of Women With Polycystic Ovary Syndrome.

Authors:  Laura C Torchen; Jan Idkowiak; Naomi R Fogel; Donna M O'Neil; Cedric H L Shackleton; Wiebke Arlt; Andrea Dunaif
Journal:  J Clin Endocrinol Metab       Date:  2016-03-18       Impact factor: 5.958

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.